AGR2 and neoplasm: This indicates that mRNA production is probably the primary control point for expression of AGR2 and is consistent with the mRNA-based subtractive hybridisation approach used to first identify AGR2 as a potential marker of aggressive ERα-positive tumours (Liu et al, 2005).